Rethinking column preparation as a strategic manufacturing capability Biopharmaceutical manufacturing is increasingly constrained by downstream processing capacity, operational complexity, and compressed manufacturing timelines. As manufacturers adopt more flexible and intensified production models, column preparation is evolving from a routine operational activity into a strategic contributor to manufacturing readiness, scalability, and operational efficiency.
This paper explores how service-based column preparation models, specialist packing expertise, and improved resin management strategies can help reduce operational burden, improve manufacturing responsiveness, and unlock hidden value across downstream manufacturing operations.
Introduction Biopharmaceutical manufacturing operations are undergoing significant transformation. Over the past two decades, upstream process intensification has dramatically increased manufacturing productivity, with upstream titers increasing more than tenfold in many biologics processes. While these gains have improved output and process efficiency, they have simultaneously increased pressure on downstream processing (DSP) operations. As a result, downstream operations are increasingly becoming the primary manufacturing bottleneck within biologics production. Chromatography remains one of the most resource-intensive and operationally critical areas within DSP, contributing significantly to manufacturing cost, operational complexity, and facility scheduling constraints. DSP can represent between 50–80% of total biologics manufacturing cost, with chromatography accounting for a substantial proportion of downstream operating expense. At the same time, manufacturing organizations are under increasing pressure to accelerate clinical timelines, improve facility utilization, support flexible manufacturing strategies, and reduce operational burden across GMP operations. These pressures are driving broader adoption of single-use
technologies, continuous downstream processing, modular manufacturing approaches, and flexible operational models. Within this evolving manufacturing landscape, column preparation is evolving from a supporting operational activity into a strategically important contributor to manufacturing responsiveness, facility utilization, and scalability.
The growing operational burden of column preparation Column preparation has traditionally been managed internally within manufacturing operations. However, at commercial and clinical scale, this model can create substantial operational burden. Internal preparation activities frequently involve multi-week setup and validation timelines, dedicated facility space, specialist operational expertise, HETP qualification testing, cleaning and turnaround activities, and extensive coordination across manufacturing schedules. As manufacturing cycles compress and facility utilization expectations increase, these activities become more difficult to manage efficiently. Internal preparation models may initially appear operationally straightforward, but they can create hidden manufacturing risk when resources, timelines, and facility schedules become constrained. The operational risk associated with internal column preparation extends beyond labor requirements alone. Poor packing reproducibility can lead to repacking activities, additional qualification testing, increased buffer consumption,
astreabioseparations.com